Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

(E)-[6]-Dehydroparadol

Cat. No.: IBDI-433162

(E)--Dehydroparadol, an oxidative metabolite of -Shogaol (HY-14616), is a potent Nrf2 activator. (E)--Dehydroparadol can inhibit the growth and induce the apoptosis of human cancer cells.

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target Apoptosis | Keap1-Nrf2
Molecular Weight 276.37
Appearance Solid
SMILES CCCCCCCC(/C=C/C1=CC=C(O)C(OC)=C1)=O
Purity ≥95.0%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.